SUBSCRIBE: Print / Digital / eNewsletter
Governments and the scientific community are racing to identify new and existing drugs that might help in the fight against the novel coronavirus. Read from experts as they discuss virulence, potential treatments and controversies surrounding COVID-19. (Steiks - stock.adobe.com)
Introducing The Mainstream Patient, a weekly glimpse into what your patients may be reading in the media about skin health.
Nuogen Pharma’s mission is to deliver the first FDA-approved anti-itch medication for chronic pruritus of unknown origin (CPUO) and other chronic itch conditions.
Experts sent a letter to the White House Coronavirus Task Force March 24, outlining concerns about a growing shortage of medications required for managing patients with lupus and rheumatoid arthritis after President Donald Trump said in a March 19 press conference that the anti-malaria drug hydroxychloroquine could treat COVID-19.
Introducing The Mainstream Patient, a weekly glimpse into what your patients may be reading in the media about skin health.
The Journal of Drugs in Dermatology is making additional resources available to medical professionals who wish to continue their education in light of medical conference cancelations due to COVID-19.
As the national pandemic continues to escalate, the American Academy of Dermatology is actively compiling resources related to the novel coronavirus to support its members and their practices.
The American Academy of Dermatology (AAD) has issued interim recommendations for practitioners to balance the risk of immunosuppression with the risk of disease flare amid COVID-19 pandemic.
In this Cosmetic Conundrum article, Zoe Diana Draelos, M.D., discusses how cosmeceuticals can be modified to address the diurnal variation in skin needs that occur during the body's circadian rhythm.
Physicians will need telehealth during the coronavirus outbreak, especially senior patients.
![intense pulse light treatment for acne](https://www.dermatologytimes.com/sites/default/files/styles/trc_article_348x228/public/Intense%20pulse%20light%20treatment%20for%20acne%20%28%C2%A9AdobeStock_83008210%29_0.jpeg?itok=wApl71kh "<p>"While the review is a good collection and summarization of a lot of studies,” says Emmy Graber, M.D., MBA, who was not involved with the study, “there’s a paucity of large-scale, randomized, controlled studies looking at the pulsed dye laser for nonvascular indications." <small>(Andrey Popov - stock.adobe.com)</small></p>")
The 595 nm pulsed dye laser (PDL) may provide an effective option for nonvascular conditions, such as scars, acne and molluscum contagiosum, according to a recent review.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.
